Literature DB >> 8316809

The tale of parathyroid function in idiopathic hypercalciuria.

B Hess1, P Jaeger.   

Abstract

At the origin, idiopathic hypercalciuria has been described as a syndrome consisting of normocalcemia, low plasma phosphate levels and abnormally high urinary calcium excretion. The cause of this syndrome was subject to many investigations throughout the years. Two main pathophysiologic hypotheses have been proposed: a) primary intestinal hyperabsorption of calcium, leading to depression of parathyroid hormone (PTH) secretion ("absorptive" hypercalciuria); and b) primary renal tubular leak of calcium which stimulates PTH secretion (secondary hyperparathyroidism). Most of the published studies indicate that intestinal hyperabsorption of calcium with subsequent relative hypoparathyroidism is the primary event causing idiopathic hypercalciuria, and that this occurs as a consequence of increased production of 1,25(OH)2-vitamin D3 (calcitriol). Fasting hypercalciuria, originally taken as evidence for a "renal leak" of calcium, appears to be, at least in part, the consequence of relative hypoparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8316809

Source DB:  PubMed          Journal:  Scanning Microsc        ISSN: 0891-7035


  4 in total

1.  Does idiopathic hypercalciuria affect bone metabolism during childhood? A prospective case-control study.

Authors:  Maria Pavlou; Vasileios Giapros; Anna Challa; Nikolaos Chaliasos; Ekaterini Siomou
Journal:  Pediatr Nephrol       Date:  2018-07-25       Impact factor: 3.714

2.  Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.

Authors:  Elizabeth A Streeten; Amy S Rogstad; Kristin M Flammer; Kiarash Zarbalian; Kathleen Ryan; Mara Horwitz; Michael F Holick; John Shelton
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

3.  Role of 1,25-dihydroxy vitamin D3 and parathyroid hormone in urinary calcium excretion in calcium stone formers.

Authors:  Won Tae Kim; Yong-June Kim; Seok Joong Yun; Kyung-Sub Shin; Young Deuk Choi; Sang Cheol Lee; Wun-Jae Kim
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

4.  Autosomal Dominant Hypocalcemia With Atypical Urine Findings Accompanied by Novel CaSR Gene Mutation and VitD Deficiency.

Authors:  Tomoya Tsuji; Ariyasu Hiroyuki; Shinsuke Uraki; Asako Doi; Shuhei Morita; Hiroshi Iwakura; Masahiro Nishi; Hiroto Furuta; Takashi Akamizu
Journal:  J Endocr Soc       Date:  2020-12-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.